Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine β-synthase gene, and pyridoxal-5'-phosphate concentration

Molecular Genetics and Metabolism

Volumn 67, Issue 4, 1999, Pages 352-356

  Tsai, Michael Y ^a   Yang, Feng ^a   Bignell, Michelle ^a   Aras, Ömer ^a   Hanson, Naomi Q ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cystathionine synthase; Homocysteine; Methionine loading; Pyridoxal 5' phosphate (vitamin B6)

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

EID: 0032817585     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2874     Document Type: Article

References (25)

1. Selhub J, Jacques P F, Bostom A G, Agostino R B, Wilson P WF, Belanger A J, O'Leary D H, Wolf P A, Schaefer E J, Rosenberg I H. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med. 332:1995;286-291.
2. Graham I M, Daly L E, Refsum H M, Robinson K, Brattstropm L E, Ueland P M, Palma-Reis R J, Boers G H, Sheahan R G, Israelsson B, Uiterwaal C S, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht J C, de Valk H W, Sales Luis A C, Parrot-Roulaud F M, Tan K S, Higgins I, Garcon D, Medrano M J, Candito M, Evans A RE, Andria G. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc. 277:1997;1775-1781.
3. Stampfer M J, Malinow M R, Willet W C, Newcomer L M, Upson B, Ullmann D, Tishler P V. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc. 268:1992;877-881.
4. Arnesen E, Refsum H, Bonaa K H, Ueland P M, Forde O H, Nordrehaug J E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:1995;704-709.
5. Perry I I, Refsum H, Morris R W, Ebrahim S B, Ueland P M, Shaper A G. Prospective study of serum homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
6. Boushey C J, Beresford S AA, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. J Am Med Assoc. 274:1995;1049-1057.
7. Tsai M Y, Welge B C, Hanson N Q, Bignell M K, Vessey J, Schwichtenberg K, Yang F, Bullemer F E, Rasmusen R, Graham K J. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis. 143:1999;163-170.
8. Bostom A G, Selhub J, Jacques P F, Nadeau M R, Williams R R, Ellison R C. Methionine intolerance with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study. Irish J Med Sci. 164s:1995;3.
9. Selhub J, Jacques P F, Wilson P WF, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. J Am Med Assoc. 270:1993;2693-2698.
10. Jacques P F, Bostom A G, Williams R R, Ellison R C, Eckfeldt J H, Rosenberg I H, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
11. Kang S S, Wong P, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet. 48:1991;536-545.
12. Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Matthews R G, Boers G JH, den Heijer M, Kluijtmans L AJ, van den Heuvel L P, Rozen R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet. 10:1995;111-113.
13. Boers G HJ, Smals A GH, Trijbels F JM, Fowler B, Bakkeren J AJM, Schoonderwaldt H C, Kleijer W, Kloppenborg P W. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 313:1985;709-715.
14. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med. 324:1991;1149-1155.
15. Kluijtmans L A, van den Heuvel L PWJ, Boers G HJ, Frosst P, Stevens E, van Oost B A, den Heijer M, Trijbels F J, Rozen R, Blom H J. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 58:1996;35-41.
16. Folsom A R, Nieto F J, McGovern P G, Tsai M Y, Malinow M R, Eckfeldt J H, Hess D L, Davis C E. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 98:1998;204-210.
17. Tsai M Y, Bignell M, Schwichtenberg K, Hanson N Q. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet. 59:1996;1262-1267.
18. Sperandeo M P, de Franchis R, Andria G, Sebastio G. A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine β-synthase mRNA. Am J Hum Genet. 59:1996;1391-1393.
19. Kluijtmans L AJ, Boers G HJ, Trijbels F JM, van Lith-Zanders H MA, van den Heuvel L PWJ, Blom H J. A common 844ins68 insertion variant in the cystathionine β-synthase gene. Biochem Mol Med. 62:1997;23-25.
20. Ramsbottom D, Scott J M, Molloy A, Weir D G, Kirke P N, Mills J L, Gallagher P M, Whitehead A S. Are common mutations of cystathionine β-synthase involved in the aetiology of neural tube defects? Clin Genet. 51:1997;39-42.
21. Ubbink J B, Hayward V WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441-446.
22. Sebastio G, Sperandeo M P, Panico M, de Franchis R, Kraus J P, Andria G. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet. 56:1995;1324-1333.
23. Damert A, Leibiger B, Leibiger I B. Dual function of the intron of the rat insulin I gene in regulation of gene expression. Diabetologia. 39:1996;1165-1172.
24. Huang Y, Carmichael G G. A suboptimal 5′ splice site is a cis-acting determinant of nuclear export of polyomavirus late mRNAs. Mol Cell Biol. 16:1996;6046-6054.
25. Maylankar U M, Rittling S R, Senhardt D T. Instability of endogenous MRP/proliferin transcripts in the nucleus of mouse embryo fibroblasts contrasts with their stability when produced during transient transfections. J Cell Biochem. 60:1996;198-210.